Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Long-term outcomes of deep brain stimulation in severe Parkinson's disease utilizing UPDRS III and modified Hoehn and Yahr as a severity scale.

Kahn L, Mathkour M, Lee SX, Gouveia EE, Hanna JA, Garces J, Scullen T, McCormack E, Riffle J, Glynn R, Houghton D, Lea G, Biro EE, Bui CJ, Sulaiman OA, Smith RD.

Clin Neurol Neurosurg. 2019 Apr;179:67-73. doi: 10.1016/j.clineuro.2019.02.018. Epub 2019 Feb 21.

PMID:
30851616
2.

Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.

Hanna JA, Scullen T, Kahn L, Mathkour M, Gouveia EE, Garces J, Evans LM, Lea G, Houghton DJ, Biro E, Bui CJ, Sulaiman OA, Smith RD.

J Neurosurg. 2018 Sep 1:1-6. doi: 10.3171/2018.4.JNS171909. [Epub ahead of print]

PMID:
30265192
3.

Endovascular Management of a Ruptured Basilar Perforator Artery Aneurysm Associated with a Pontine Arteriovenous Malformation: Case Report and Review of the Literature.

Lockwood J, Scullen T, Mathkour M, Kaufmann A, Medel R, Dumont AS, Amenta PS.

World Neurosurg. 2018 Aug;116:159-162. doi: 10.1016/j.wneu.2018.05.051. Epub 2018 May 16. Review.

PMID:
29777889
4.

Endovascular Management of Multiple Dysplastic Aneurysms in a Young Man with an Unknown Underlying Cause: A Case Report and Review of the Literature.

Scullen T, Mathkour M, Lockwood J, Ott L, Medel R, Dumont AS, Amenta PS.

World Neurosurg. 2018 Mar;111:349-357. doi: 10.1016/j.wneu.2017.12.129. Epub 2017 Dec 28. Review.

PMID:
29289804
5.

First Case of Autonomic Dysreflexia Following Elective Lower Thoracic Spinal Cord Transection in a Spina Bifida Adult.

Garces J, Mathkour M, Scullen T, Kahn L, Biro E, Pham A, Sulaiman OAR, Smith R, Bui CJ.

World Neurosurg. 2017 Dec;108:988.e1-988.e5. doi: 10.1016/j.wneu.2017.07.147. Epub 2017 Aug 3.

PMID:
28782691
6.

Spindle cell oncocytoma of the pituitary gland.

Mathkour M, Garces J, Scullen T, Valle-Giler E, Halat S, Arrington T, Ware M.

J Neurosurg Sci. 2017 Oct;61(5):554-557. doi: 10.23736/S0390-5616.16.03433-0. No abstract available.

PMID:
28737368
7.

Mini-Open Thoracolumbar Corpectomy: Perioperative Outcomes and Hospital Cost Analysis Compared with Open Corpectomy.

Sulaiman OAR, Garces J, Mathkour M, Scullen T, Jones RB, Arrington T, Bui CJ.

World Neurosurg. 2017 Mar;99:295-301. doi: 10.1016/j.wneu.2016.11.075. Epub 2016 Nov 25.

PMID:
27890745
8.

Short- and Long-Term Outcomes of Deep Brain Stimulation in Patients 70 Years and Older with Parkinson Disease.

Mathkour M, Garces J, Scullen T, Hanna J, Valle-Giler E, Kahn L, Arrington T, Houghton D, Lea G, Biro E, Bui CJ, Sulaiman OA, Smith RD.

World Neurosurg. 2017 Jan;97:247-252. doi: 10.1016/j.wneu.2016.06.001. Epub 2016 Jun 11.

PMID:
27297246
9.

Sensitization of the Hypothalamic-Pituitary-Adrenal Axis in a Male Rat Chronic Stress Model.

Franco AJ, Chen C, Scullen T, Zsombok A, Salahudeen AA, Di S, Herman JP, Tasker JG.

Endocrinology. 2016 Jun;157(6):2346-55. doi: 10.1210/en.2015-1641. Epub 2016 Apr 7.

10.

Primary Intraventricular Leiomyoma in an Immunocompetent Patient: First Case Report and Review of the Literature.

Garces J, Mathkour M, Valle-Giler E, Scullen T, Berry JF, Smith RD.

World Neurosurg. 2016 Jun;90:698.e13-698.e18. doi: 10.1016/j.wneu.2016.01.088. Epub 2016 Feb 5. Review.

PMID:
26855311
11.

Cryptogenic stroke: clinical consideration of a heterogeneous ischemic subtype.

Scullen TA, Monlezun DJ, Siegler JE, George AJ, Schwickrath M, El Khoury R, Cho MC, Martin-Schild S.

J Stroke Cerebrovasc Dis. 2015 May;24(5):993-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.024. Epub 2015 Mar 23.

PMID:
25813058
12.

Erythropoietin negatively regulates pituitary ACTH secretion.

Dey S, Scullen T, Noguchi CT.

Brain Res. 2015 May 22;1608:14-20. doi: 10.1016/j.brainres.2015.02.052. Epub 2015 Mar 9.

13.

Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.

Patel CG, Yee AJ, Scullen TA, Nemani N, Santo L, Richardson PG, Laubach JP, Ghobrial IM, Schlossman RL, Munshi NC, Anderson KC, Raje NS.

Clin Cancer Res. 2014 Aug 1;20(15):3955-61. doi: 10.1158/1078-0432.CCR-14-0434. Epub 2014 Jun 23.

14.

Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide.

Yee AJ, Hari P, Marcheselli R, Mahindra AK, Cirstea DD, Scullen TA, Burke JN, Rodig SJ, Hideshima T, Laubach JP, Ghobrial IM, Schlossman RL, Munshi NC, Anderson KC, Weller EA, Richardson PG, Raje NS.

Br J Haematol. 2014 Aug;166(3):401-9. doi: 10.1111/bjh.12909. Epub 2014 Apr 25.

PMID:
24761838
15.

A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity.

Eda H, Santo L, Cirstea DD, Yee AJ, Scullen TA, Nemani N, Mishima Y, Waterman PR, Arastu-Kapur S, Evans E, Singh J, Kirk CJ, Westlin WF, Raje NS.

Leukemia. 2014 Sep;28(9):1892-901. doi: 10.1038/leu.2014.69. Epub 2014 Feb 12.

PMID:
24518207
16.

Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy.

Scullen T, Santo L, Vallet S, Fulciniti M, Eda H, Cirstea D, Patel K, Nemani N, Yee A, Mahindra A, Raje N.

Leukemia. 2013 Aug;27(8):1715-21. doi: 10.1038/leu.2013.50. Epub 2013 Feb 18.

PMID:
23417027
17.

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.

Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, Cirstea D, Rodig S, Eda H, Scullen T, Canavese M, Bradner J, Anderson KC, Jones SS, Raje N.

Blood. 2012 Mar 15;119(11):2579-89. doi: 10.1182/blood-2011-10-387365. Epub 2012 Jan 19.

Supplemental Content

Loading ...
Support Center